Global Cancer Cognitive Computing Market Outlook 2022

Published: Nov, 2016 | Pages: 100 | Publisher: RNCOS
Industry: Healthcare | Report Format: Electronic (PDF)

The emergence of Cognitive Computing for Cancer has revolutionized the healthcare industry. This technique is allowing a previously unattainable level of personalized treatment options with efficiency and simplicity. Due to this ability, it is anticipated that the Global Cancer Cognitive Computing market will cross US$ 4 Billion by 2022. The growth of the market is likely to be driven by advancements in computing platforms, rising installation of cognitive computing software in hospitals, increasing large and complex genomic datasets, and growing cancer incidences.

The report, "Global Cancer Cognitive Computing Market Outlook 2022", provides an insight of the current and future prospective of this market. This report covers the major opportunities in this area, and the factors impacting the market growth. Furthermore, the report also provides insight regarding the trends persisting in the market.

Global as well as regional prevalence of cancer is also discussed in the report. This will help the reader to understand the potential of each region for cognitive computing for cancer. Moreover, the report also estimates the number of cancer specialty hospital in each region, with name of major hospitals. These hospitals could be the target for the incorporation of cancer cognitive computing solutions.

The report contains the Cancer Cognitive Computing market share of major regions, including North America, Europe, Asia-Pacific, and the Rest of the World. North America holds the largest market share, while Asia-Pacific is expected to witness highest growth in the coming years, i.e. 2016-2022. The major reasons for the high growth in Asia-Pacific are the ongoing researches in China and Japan, which is expanding cognitive computing applications to oncology. North America and Europe are expected to grow at a modest rate due to launch of new and innovative products in this market.

The last segment of the report is entirely devoted to profiling leading companies of the Cancer Cognitive Computing industry, including some major players like IBM, Microsoft, Google, Apple, Palantir, Palantir, Alacris, Enterra Solutions, GE Healthcare, etc. This segment provides access to the financials, product, services or technology portfolio, and recent developments of these companies. This segment also discusses the strengths and weaknesses of key players in this industry. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global Cancer Cognitive Computing market.

Table of Contents
1. Analyst View

2. Research Methodology

3. Cognitive Computing for Cancer: An Overview

4. Market Dynamics
4.1 Drivers
4.1.1 Increasing Adoption of Watson for Cancer Treatment
4.1.2 Rise in Number of Collaborations to Ramp-up Cancer Treatment
4.1.3 Ability of Cognitive Computing to Enhance the Efficiency and Effectiveness of Treatment
4.1.4 Ability to Analyze Extensive Cancer & Genome Data
4.1.5 Rising Incidences of Cancer
4.1.6 Advancements in Cognitive Computing Platforms
4.1.7 Bolstering Internet Speed
4.2 Restraints
4.2.1 High Cost for Cognitive Computing Systems
4.2.2 Lack of Expertise for Cognitive Computing
4.3 Opportunities
4.3.1 Increasing Adoption of Cloud Based Technology
4.3.2 Latin America & Africa Offers Array of Opportunities for Market Growth

5. Cancer Demographics
5.1 North America
5.2 Europe
5.3 Asia Pacific
5.4 Rest of the World

6. Cancer Cognitive Computing Market Outlook
6.1 By Geography

7. Trends & Developments in Cancer Cognitive Computing
7.1 Mobile Oncology App for Cancer Care
7.2 Establishment of Cognitive Ecosystems of Third Party Organizations
7.3 Start-ups Entering Cognitive Computing Specialized for Healthcare

8. Mergers, Acquisitions & Partnerships

9. Company Profiles
9.1 Apple Inc.
9.2 IBM Corporation
9.3 Microsoft Corporation
9.4 Google Inc.
9.5 Lockheed Martin Corporation
9.6 GE Healthcare
9.7 CognitiveScale Inc.
9.8 Enterra Solutions, LLC
9.9 Saffron Technology, Inc. (A Subsidiary of Intel Corporation)
9.10 Apixio, Inc.,
9.11 Alacris Theranostics GmbH
9.12 Palantir Technologies

List of Tables:
 
Table 5-1: Global - Cancer Prevalence (Million), 2015 & 2025
Table 5-2: Global - Cancer Incidences (Million), 2015 & 2025
Table 5-3: North America - Cancer Prevalence (Million), 2015 & 2025
Table 5-4: North America - Cancer Incidences (Million), 2015 & 2025
Table 5-5: US - Cancer Prevalence (Million), 2015 & 2025
Table 5-6: US - Cancer Incidences (Million), 2015 & 2025
Table 5-7: Canada - Cancer Prevalence (Million), 2015 & 2025
Table 5-8: Canada - Cancer Incidences (Million), 2015 & 2025
Table 5-9: Europe - Cancer Incidences (Million), 2015 & 2025
Table 5-10: Europe - Cancer Prevalence (Million), 2015 & 2025
Table 5-11: UK - Cancer Prevalence (Million), 2015 & 2025
Table 5-12: UK - Cancer Incidences (Million), 2015 & 2025
Table 5-13: France - Cancer Prevalence (Million), 2015 & 2025
Table 5-14: France - Cancer Incidences (Million), 2015 & 2025
Table 5-15: Germany - Cancer Prevalence (Million), 2015 & 2025
Table 5-16: Germany - Cancer Incidences (Million), 2015 & 2025
Table 5-17: Spain - Cancer Prevalence (Million), 2015 & 2025
Table 5-18: Spain - Cancer Incidences (Million), 2015 & 2025
Table 5-19: Italy - Cancer Prevalence (Million), 2015 & 2025
Table 5-20: Italy - Cancer Incidences (Million), 2015 & 2025
Table 5-21: Norway - Cancer Prevalence (Million), 2015 & 2025
Table 5-22: Norway - Cancer Incidences (Million), 2015 & 2025
Table 5-23: Asia Pacific - Cancer Prevalence (Million), 2015 & 2025
Table 5-24: Asia Pacific - Cancer Incidences (Million), 2015 & 2025
Table 5-25: India - Cancer Prevalence (Million), 2015 & 2025
Table 5-26: India - Cancer Incidences (Million), 2015 & 2025
Table 5-27: China - Cancer Prevalence (Million), 2015 & 2025
Table 5-28: China - Cancer Incidences (Million), 2015 & 2025
Table 5-29: Japan - Cancer Prevalence (Million), 2015 & 2025
Table 5-30: Japan - Cancer Incidences (Million), 2015 & 2025
Table 5-31: Asutralia - Cancer Prevalence (Million), 2015 & 2025
Table 5-32: Australia - Cancer Incidences (Million), 2015 & 2025
Table 5-33: New Zealand - Cancer Prevalence (Million), 2015 & 2025
Table 5-34: New Zealand - Cancer Incidences (Million), 2015 & 2025
Table 5-35: Malaysia - Cancer Prevalence (Million), 2015 & 2025
Table 5-36: Malaysia - Cancer Incidences (Million), 2015 & 2025
Table 5-37: Rest of the World - Cancer Prevalence (Million), 2015 & 2025
Table 5-38: Rest of the World - Cancer Incidences (Million), 2015 & 2025
Table 5-39: Latin America - Cancer Prevalence (Million), 2015 & 2025
Table 5-40: Latin America - Cancer Incidences (Million), 2015 & 2025
Table 5-41: Africa - Cancer Prevalence (Million), 2015 & 2025
Table 5-42: Africa - Cancer Incidences (Million), 2015 & 2025
Table 6-1: Global - Total Number of Major Cancer Specialty Hospitals
Table 6-2: North America - Total Number of Major Cancer Specialty Hospitals
Table 6-3: North America - Major Cancer Specialty Hospitals
Table 6-4: Europe - Total Number of Major Cancer Specialty Hospitals
Table 6-5: Europe - Major Cancer Specialty Hospitals
Table 6-6: Asia Pacific - Total Number of Major Cancer Specialty Hospitals
Table 6-7: Asia Pacific - Major Cancer Specialty Hospitals
Table 6-8: Rest of the World - Total Number of Major Cancer Specialty Hospitals
Table 6-9: Rest of the World - Major Cancer Specialty Hospitals
Table 9-1: Apple Inc. - Product Pipeline
Table 9-2: Apple Inc. - Key Financials (Million US$), 2013-2015
Table 9-3: IBM Corporation - Product Portfolio
Table 9-4: IBM Corporation - Key Financials (Million US$), 2013-2015
Table 9-5: Microsoft Corporation - Project Portfolio
Table 9-6: Microsoft Corporation - Product Pipeline
Table 9-7: Microsoft Corporation - Key Financials (Million US$), 2013-2015
Table 9-8: Google Inc. - Product Pipeline
Table 9-9: Google Inc. - Key Financials (Million US$), 2013-2015
Table 9-10: Lockheed Martin Corporation - Service Pipeline
Table 9-11: Lockheed Martin Corporation - Key Financials (Million US$), 2013-2015
Table 9-12: GE Healthcare - Service Portfolio
Table 9-13: GE Healthcare - Key Financials (Million US$), 2013-2015
Table 9-14: CognitiveScale Inc. - Services Portfolio
Table 9-15: CognitiveScale Inc. - Product Pipeline
Table 9-16: Enterra Solutions, LLC - Services Portfolio
Table 9-17: Saffron Technology, Inc. - Products & Services Pipeline
Table 9-18: Apixio, Inc., - Technology Pipeline
Table 9-19: Alacris Theranostics GmbH - Technology Portfolio
Table 9-20: Palantir Technologies - Service Pipeline